Aminogen® May Benefit Muscle Loss Applications

October 29, 2008

2 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

WAYNE, N.J.—According to Triarco Industries, analysis of clinical research on Aminogen® suggests the patented enzyme’s ability to triple the rate of protein absorption and increase levels of free and branched-chain amino acids (BCAAs) absorbed from protein may be beneficial in natural products targeting sarcopenia. Aminogen was shown in a recently published clinical study to increase free amino acid levels by 100 percent, BCAAs by 250 percent and nitrogen retention by 32 percent.
Sarcopenia, the loss of muscle mass associated with aging, can occur as the body becomes less efficient at digesting protein. It is thought to be caused by a combination of physiological and lifestyle changes brought on by age, including engaging in little or no weight-bearing exercise, eating less protein as it becomes more difficult to cook and chew, a slowing metabolic rate and a decrease in certain hormones and endogenous digestive enzymes.
“As a patented proteolytic enzyme system, Aminogen is relevant in sarcopenia applications for three reasons,” said director of Triarco R&D, Dr. Mark Anderson. “First, Aminogen is clinically proven to increase the rate of protein absorption, so more amino acids are made available to the body before the protein moves further down the digestive tract is no longer bioavailable. Second, Aminogen increases BCAA levels alone by 250 percent. These amino acids are crucial for building and maintaining skeletal muscle. Third, Aminogen increases nitrogen retention by 32 percent. This is important because we know that inefficient nitrogen retention leads to a catabolic state in which your body loses protein, and breaks down muscle tissue to make up the difference. Adding Aminogen to protein helps to protect against this.” Aminogen’s ability to break down protein can also lead to the reduction or elimination of gastrointestinal symptoms that can result from incomplete protein digestion, a problem that can discourage older adults from consuming adequate protein. Consumer and industry interest in Aminogen has intensified as the enzyme system was GRAS (generally recognized as safe) affirmed protein snacks and beverages earlier this year, followed by the publication of a clinical study on the enzyme system in the Journal for the International Society of Sports Nutrition.

www.AminogenBlog.com

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like